Sandimmune (Novartis)
Sandimmune (Novartis) Brand names, Sandimmune (Novartis) Analogs
Sandimmune (Novartis) Brand Names Mixture
- No information avaliable
Sandimmune (Novartis) Chemical_Formula
C62H111N11O12
Sandimmune (Novartis) RX_link
http://www.rxlist.com/cgi/generic3/restasis.htm
Sandimmune (Novartis) fda sheet
Sandimmune (Novartis) msds (material safety sheet)
Sandimmune (Novartis) Synthesis Reference
No information avaliable
Sandimmune (Novartis) Molecular Weight
1202.61
Sandimmune (Novartis) Melting Point
No information avaliable
Sandimmune (Novartis) H2O Solubility
No information avaliable
Sandimmune (Novartis) State
Liquid
Sandimmune (Novartis) LogP
4.293
Sandimmune (Novartis) Dosage Forms
Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)
Sandimmune (Novartis) Indication
For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis
Sandimmune (Novartis) Pharmacology
Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.
Sandimmune (Novartis) Absorption
No information avaliable
Sandimmune (Novartis) side effects and Toxicity
No information avaliable
Sandimmune (Novartis) Patient Information
BIOD00003.html
Sandimmune (Novartis) Organisms Affected
Humans and other mammals
